Table 1 Patient demographics and medical history
Before PBPM | After PBPM | p-value | |||
|---|---|---|---|---|---|
Number of patients | 17 | 23 | |||
Other infectious diseases | HBV co-infection | 2 | HBV co-infection | 5 | |
HCV co-infection | 0 | HCV co-infection | 2 | ||
Syphilis infection | 4 | Syphilis infection | 5 | ||
Nationality (M/F) | Japanese (9/1) 58% | Japanese (18/0) 78% | |||
Other (2/5) 41% | Other (4/1) 22% | ||||
Age | 43 [30–59] | 38 [20–69] | 0.237 | ||
ART regimen | LPV/r + TDF/FTC | 6 | DRV + RTV + TDF/FTC | 7 | |
RAL + TDF/FTC | 4 | EVG/cobi/TDF/FTC | 5 | ||
EFV + TDF/FTC | 3 | DTG + TDF/FTC | 5 | ||
DRV + RTV + TDF/FTC | 2 | RAL + TDF/FTC | 3 | ||
other | 2 | other | 3 | ||
HIV-RNA level at the start of treatment (copy/mL) | 27,400 [N.D.–349,000] | 44,900 [N.D.–100,000,000] | 0.330 | ||